Skip to main content

Table 1 Clinical features of UCS and CCS n (%)

From: Clinical and imaging features of carcinosarcoma of the uterus and cervix

Features

UCS (nā€‰=ā€‰37)

CCS (nā€‰=ā€‰4)

p value

Age, years

59.92ā€‰Ā±ā€‰7.40

69.25ā€‰Ā±ā€‰6.40

0.020

Childbearing history

3 (2, 3)

3.50 (2.25, 5.50)

0.190

Chief complaint

Vaginal bleeding

29 (78.37)

4 (100)

0.569

Other

8 (21.62)

0

Ā 

Duration

ā‰¤ā€‰2Ā month

24 (64.86)

1 (15)

0.311

>ā€‰2Ā month

13 (35.14)

3 (75)

Ā 

Postmenopausal

Yes

36 (97.29)

4 (100)

1.000

No

1 (2.7)

0

Ā 

AFP

Elevated/normal

3/34

0/4

1.000

CEA

Elevated/normal

0/37

0/4

ā€“

CA199

Elevated/normal

3/34

0/4

1.000

CA125

Elevated/normal

13/24

0/4

0.385

CA153

Elevated/normal

1/36

0/4

1.000

CA724

Elevated/normal

1/36

0/4

1.000

Invasion depth

ā‰¤ā€‰1/2 myometrium

19 (51.35)

ā€“

ā€“

>ā€‰1/2 myometrium

18 (48.64)

ā€“

Ā 

Stage

IA/ IB

17/9

4

0.496

II

1

0

Ā 

IIIA/B/C1/C2

2/1/1/2

0

Ā 

IVB

4

0

Ā 
  1. Bold value means pĀ <Ā 0.05
  2. UCS uterine carcinosarcoma, CCS cervical carcinosarcoma, AFP alpha-fetoprotein, CEA carcinoembryonic antigen, CA199 carbohydrate antigen 199, CA125 carbohydrate antigen 125, CA153 carbohydrate antigen 153, CA724 carbohydrate antigen 724